BIOMAT Database Logo BIOMAT Database Logo

Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. 1991

C Szczylik, and T Skorski, and N C Nicolaides, and L Manzella, and L Malaguarnera, and D Venturelli, and A M Gewirtz, and B Calabretta
Department of Pathology, Temple University Medical School, Philadelphia, PA 19140.

To determine the role of the BCR-ABL gene in the proliferation of blast cells of patients with chronic myelogenous leukemia, leukemia blast cells were exposed to synthetic 18-mer oligodeoxynucleotides complementary to two identified BCR-ABL junctions. Leukemia colony formation was suppressed, whereas granulocyte-macrophage colony formation from normal marrow progenitors was unaffected. When equal proportions of normal marrow progenitors and blast cells were mixed, exposed to the oligodeoxynucleotides, and assayed for residual colony formation, the majority of residual cells were normal. These findings demonstrate the requirement for a functional BCR-ABL gene in maintaining the leukemic phenotype and the feasibility of gene-targeted selective killing of neoplastic cells.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D001752 Blast Crisis An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%. Blast Phase,Blast Crises,Blast Phases,Crises, Blast,Crisis, Blast,Phase, Blast,Phases, Blast
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D001613 beta 2-Microglobulin An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants. Thymotaxin,beta 2 Microglobulin
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

C Szczylik, and T Skorski, and N C Nicolaides, and L Manzella, and L Malaguarnera, and D Venturelli, and A M Gewirtz, and B Calabretta
Gene-targeted specific inhibition of chronic myeloid leukemia cell growth by BCR-ABL antisense oligodeoxynucleotides.
January 1991, Folia histochemica et cytobiologica,
C Szczylik, and T Skorski, and N C Nicolaides, and L Manzella, and L Malaguarnera, and D Venturelli, and A M Gewirtz, and B Calabretta
Morpholino Oligo Antisense efficiently suppresses BCR/ABL and cell proliferation in CML: specific inhibition of BCR-ABL gene expression by Morpholino Oligo Antisense in BCR-ABL(+) cells.
January 2012, Hematology (Amsterdam, Netherlands),
C Szczylik, and T Skorski, and N C Nicolaides, and L Manzella, and L Malaguarnera, and D Venturelli, and A M Gewirtz, and B Calabretta
Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores beta1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors.
May 1998, Blood,
C Szczylik, and T Skorski, and N C Nicolaides, and L Manzella, and L Malaguarnera, and D Venturelli, and A M Gewirtz, and B Calabretta
Antisense inhibition of P210 bcr-abl in chronic myeloid leukemia.
October 1993, Stem cells (Dayton, Ohio),
C Szczylik, and T Skorski, and N C Nicolaides, and L Manzella, and L Malaguarnera, and D Venturelli, and A M Gewirtz, and B Calabretta
Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides.
August 1992, Proceedings of the National Academy of Sciences of the United States of America,
C Szczylik, and T Skorski, and N C Nicolaides, and L Manzella, and L Malaguarnera, and D Venturelli, and A M Gewirtz, and B Calabretta
Antisense BCR-ABL oligomers cause non-specific inhibition of chronic myeloid leukemia cell lines.
December 1994, Leukemia,
C Szczylik, and T Skorski, and N C Nicolaides, and L Manzella, and L Malaguarnera, and D Venturelli, and A M Gewirtz, and B Calabretta
Elimination of clonogenic Philadelphia-positive cells using BCR-ABL antisense oligodeoxynucleotides.
September 1993, Bone marrow transplantation,
C Szczylik, and T Skorski, and N C Nicolaides, and L Manzella, and L Malaguarnera, and D Venturelli, and A M Gewirtz, and B Calabretta
Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
July 1998, Clinical cancer research : an official journal of the American Association for Cancer Research,
C Szczylik, and T Skorski, and N C Nicolaides, and L Manzella, and L Malaguarnera, and D Venturelli, and A M Gewirtz, and B Calabretta
Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides.
January 1997, Journal of the National Cancer Institute,
C Szczylik, and T Skorski, and N C Nicolaides, and L Manzella, and L Malaguarnera, and D Venturelli, and A M Gewirtz, and B Calabretta
Selective inhibition of proliferation in v-abl- and bcr-abl-transformed cells by a nucleoside analog.
November 1992, The Journal of biological chemistry,
Copied contents to your clipboard!